Last update :
18/03/2026
Anticancer drug   Obinutuzumab   
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Gazyva Argentina, Australia, Brazil, Canada, Chile, Ecuador, Mexico, Peru, United States of America
Gazyvaro Belgium, Denmark, Finland, France, Germany, Great Britain, Hungary, Iceland, Ireland, Italy, Japan, Luxembourg, Norway, Peru, Romania, Spain, Sweden, Switzerland, Tunisia
References   injection   References : Obinutuzumab   
Type Publication
2296 Manufacturer Témocilline (Negaban®) - Résumé des caractéristiques du produit
Eumedica 2017
3768 Manufacturer Obinutuzumab (Gazyvaro®) - Summary of Product Characteristics
Roche Products Limited 2025
5129 Poster Hindes E, Hassani L, Hamid O, Agnès H, Combeau D, Antignac M, Sadou Yayé H.
Evaluation de la stabilité physico-chimique de solutions diluées d'obinutuzumab (Gazyvaro®) à 0,4 mg/mL et 4 mg/mL : une étude sur 28 jours.
SFPO Congress, 15-17 October 2025, Saint-Malo, Fra 2025

  Mentions Légales